Also trades as: 6368.T (JPX) · $vol 22M
ORGJF OTC
Organo Corporation
1W: +0.0%
1M: -11.8%
3M: -18.4%
YTD: +55.6%
1Y: +57.5%
3Y: +368.7%
$16.40
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$178.8B
+9.5% ▲
5Y CAGR: +12.2%
Gross Profit
$65.5B
+18.7% ▲
5Y CAGR: +20.0%
Operating Income
$37.9B
+21.7% ▲
5Y CAGR: +31.7%
Net Income
$28.6B
+18.3% ▲
5Y CAGR: +32.2%
EPS (Diluted)
$124.31
+18.3% ▲
5Y CAGR: -4.2%
EBITDA
$39.9B
+15.5% ▲
5Y CAGR: +29.9%
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| Revenue | $112.1B | $132.4B | $150.4B | $163.3B | $178.8B |
| YoY Growth | +11.4% | +18.2% | +13.5% | +8.6% | +9.5% |
| Cost of Revenue | $83.6B | $97.4B | $106.5B | $108.1B | $113.3B |
| Gross Profit | $28.5B | $35.0B | $43.8B | $55.2B | $65.5B |
| Gross Margin | 25.4% | 26.4% | 29.2% | 33.8% | 36.6% |
| R&D Expenses | $2.1B | $2.6B | $0 | $0 | $0 |
| SG&A Expenses | $15.5B | $17.1B | $21.3B | $24.1B | $27.6B |
| Operating Expenses | $17.7B | $19.8B | $21.3B | $24.1B | $27.6B |
| Operating Income | $10.8B | $15.2B | $22.5B | $31.1B | $37.9B |
| Operating Margin | 9.7% | 11.5% | 15.0% | 19.1% | 21.2% |
| Interest Expense | $127M | $159M | $240M | $246M | $300M |
| Income Before Tax | $12.7B | $16.0B | $23.6B | $32.4B | $38.6B |
| Tax Expense | $3.5B | $4.3B | $6.3B | $8.2B | $10.0B |
| Net Income | $9.2B | $11.7B | $17.3B | $24.1B | $28.6B |
| Net Margin | 8.2% | 8.9% | 11.5% | 14.8% | 16.0% |
| EPS (Diluted) | $200.67 | $255.77 | $376.92 | $525.36 | $124.31 |
| EBITDA | $12.2B | $18.0B | $24.6B | $34.5B | $39.9B |
| Shares Outstanding | 46M | 46M | 46M | 46M | 230M |